Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Treasury Shares (2020 - 2024)

Historic Treasury Shares for Eton Pharmaceuticals (ETON) over the last 4 years, with Q4 2024 value amounting to $226068.0.

  • Eton Pharmaceuticals' Treasury Shares fell 1755.48% to $226068.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $226068.0, marking a year-over-year decrease of 1755.48%. This contributed to the annual value of $226068.0 for FY2024, which is 1755.48% down from last year.
  • According to the latest figures from Q4 2024, Eton Pharmaceuticals' Treasury Shares is $226068.0, which was down 1755.48% from $274204.0 recorded in Q4 2023.
  • In the past 5 years, Eton Pharmaceuticals' Treasury Shares ranged from a high of $369606.0 in Q3 2022 and a low of $7595.0 during Q4 2020
  • Its 4-year average for Treasury Shares is $249415.8, with a median of $274204.0 in 2023.
  • Per our database at Business Quant, Eton Pharmaceuticals' Treasury Shares crashed by 2581.18% in 2023 and then crashed by 1755.48% in 2024.
  • Quarter analysis of 4 years shows Eton Pharmaceuticals' Treasury Shares stood at $7595.0 in 2020, then skyrocketed by 4766.44% to $369606.0 in 2022, then dropped by 25.81% to $274204.0 in 2023, then decreased by 17.55% to $226068.0 in 2024.
  • Its Treasury Shares was $226068.0 in Q4 2024, compared to $274204.0 in Q4 2023 and $369606.0 in Q4 2022.